Despite better outcomes with early coronary artery reperfusion for the treatment of acute ST-
elevation myocardial infarction (MI), morbidity and mortality from acute myocardial infarction …

The no-reflow phenomenon (NRP) is defined as the lack of adequate myocardial tissue
perfusion despite a patent epicardial coronary artery. The incidence of NRP varies between …

Objective: To compare the effects of an aspirin–clopidogrel combination with those of the
specific glycoprotein IIb/IIIa inhibitor tirofiban on myocardial no-reflow, nitric oxide …

Aims The objective of the study is to assess the efficacy and safety of the novel Magic Touch
sirolimus coated-balloon (SCB) when compared to the SeQuent Please Neo paclitaxel …

In this issue of the European Heart Journal, De Luca et al., demonstrate that among 1072
patients with ST-segment elevation myocardial infarction (STEMI) treated by primary …

Recently, percutaneous coronary intervention has been the treatment of choice in most
acute myocardial infarction cases. Although the results of percutaneous coronary …

C ardiac magnetic resonance imaging (CMR) is rapidly emerging as a clinically applicable
and highly reproducible noninvasive imaging technique for assessing left ventricular (LV) …

Simvastatin can prevent cardiac remodelling after myocardial infarction, though the exact
mechanisms are uncertain. Myocardial no‐reflow is associated with progressive cardiac …

The no-reflow phenomenon (NRP) is characterized by an inadequate myocardial tissue
perfusion in the presence of a patent epicardial coronary artery. It generally occurs after …

It is being increasingly recognized that, in patients with acute myocardial infarction,
angiographically successful recanalization of the occluded artery cannot be used as a …